Oncimmune (LON:ONC) Shares Down 4.2% – Here’s Why

Oncimmune Holdings plc (LON:ONC) dropped 4.2% on Monday . The company traded as low as GBX 14.85 ($0.19) and last traded at GBX 14.85 ($0.19). Approximately 210,591 shares traded hands during trading, an increase of 72% from the average daily volume of 122,679 shares. The stock had previously closed at GBX 15.50 ($0.20).

Oncimmune Trading Up 0.3 %

The business’s 50 day simple moving average is GBX 16.49 and its two-hundred day simple moving average is GBX 16.22. The stock has a market cap of £11.20 million, a P/E ratio of -505.00 and a beta of 1.19. The company has a quick ratio of 0.63, a current ratio of 1.13 and a debt-to-equity ratio of 806.85.

Oncimmune Company Profile

Oncimmune Holdings plc, an immunodiagnostics company, develops solutions for immuno-oncology, autoimmune disease and infectious diseases in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, an immunodiagnostic blood test for detecting and identifying lung cancer; ImmunoINSIGHTS that enables life science organizations to optimize drug development and delivery; SeroTag discovery arrays for discovering and validating biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel.